Unlicensed uses for medication in a palliative care unit

Palliative Medicine

Volumn 13, Issue 2, 1999, Pages 145-152

  Atkinson, Clea V ^b   Kirkham, Stephen R ^a  

^a Forest Holme   (United Kingdom)

^b NONE

Author keywords

Drug utilization; Drugs; Neoplasms; Palliative care; Prescriptions

Indexed keywords

CLODRONIC ACID; CODANTHRAMER; DIAMORPHINE; FENTANYL; LEVOMEPROMAZINE; METHADONE; MORPHINE; SPIRONOLACTONE;

ARTICLE; ASCITES; CANCER PAIN; CANCER PALLIATIVE THERAPY; CONSTIPATION; COUGHING; DRUG USE; HUMAN; LICENCE; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; NAUSEA; ORAL DRUG ADMINISTRATION; PRESCRIPTION; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; VOMITING;

DRUG LABELING; DRUG UTILIZATION REVIEW; HUMANS; NEOPLASMS; PALLIATIVE CARE; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES;

EID: 0032951529     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/026921699676057177     Document Type: Article

References (27)

1. Anon. Prescribing unlicensed drugs or using drugs for unlicensed indications. DTB 1992; 30: 97-99.
2. Anon. How drugs get to market. DTB 1990: 28: 101-104.
3. Roy DJ, MacDonald N. Ethical issues in palliative care. In: Calman K, Hanks GWC, MacDonald N, eds. Oxford textbook of palliative medicine, 2nd edn. Oxford: Oxford University Press, 1998: 103-107.
4. ABPI data sheet compendium 1996-97. London: Datapharm Publications, 1996.
5. Ferner RE. Prescribing licensed medicines for unlicensed indications. Prescribes J 1996; 36: 73-78.
6. Tobin MJ. Dyspnea. Pathophysiologic basis, clinical presentation and management. Arch Intern Med 1990; 150: 1604-13.
7. Young IH, Daviskas E, Keena VA. Effect of low-dose nebulized morphine on exercise endurance in patients with chronic lung disease. Thorax 1989; 44: 387-90.
8. MacKay C, Murray WR, Sali A. Aluminium hydroxide in bile-salt diarrhoea. Lancet 1977; ii: 1051-53.
9. Burgstaler EA, Carlson GL, Dickson ER, Lauterburg BH, Pineda AA, Taswell HF. Treatment of pruritis of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet 1980; ii: 53-55.
10. Twycross R, Lichter I. The terminal phase. In: Calman K, Hanks GWC, MacDonald N eds. Oxford textbook of palliative medicine, 2nd edn. Oxford: Oxford University Press, 1998: 160-62.
11. Roberts CJC, Keir S, Hanks GWC. The principles of drug use in palliative medicine. In: Calman K, Hanks GWC, MacDonald N eds. Oxford textbook of palliative medicine, 2nd edn. Oxford: Oxford University Press, 1998: 227-31.
12. Doyle D. Domiciliary palliative care. In: Calman K, Hanks GWC, MacDonald N eds. Oxford textbook of palliative medicine, 2nd edn. Oxford: Oxford University Press, 1998: 957-73.
13. Thirlby RC. Toward a treatment for anorexia and cachexia in patients with cancer. Gastroenterology 1991; 101: 268-70.
14. Sykes NP, Baines M, Carter RL. Clinical and pathological study of dysphagia conservatively managed in patients with advanced malignant disease. Lancet 1988; ii: 726-28.
15. Rousseau P Non-pain symptom management in terminal care. Clin Geriatr Med 1996; 12: 313-17.
16. Mercadante S, Kargar J, Nicolosi G. Octreotide may prevent definitive intestinal obstruction. J Pain Symptom Manage 1997; 13: 352-55.
17. Hanks GW. Opioid-responsive and opioid-non-responsive pain in cancer. Br Med Bull 1991; 47: 718-31.
18. Walsh TD, West TS. Controlling symptoms in advanced cancer. Br Med J 1988; 296: 477-81.
19. Wells JCD, Miles JB. Pain clinics and pain clinic treatments. Br Med Bull 1991; 47: 762-85.
20. Richter JE, Bradley LA, Castell DO. Esophageal chest pain: current contraversies in pathogenesis, diagnosis, and therapy. Ann Intern Med 1989; 110: 66-78.
21. Ahmedzai S. Palliation of respiratory symptoms. In: Calman K, Hanks GWC, MacDonald N eds. Oxford textbook of palliative medicine, 2nd edn. Oxford: Oxford University Press, 1998: 586-604.
22. Fox PC, Atkinson JC, Macynski AA et al. Pilocarpine in the treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 1991; 151: 1149-52.
23. Bennett MI. Death rattle: an audit of hyoscine (scopalamine) use and review of management. J Pain Symptom Manage 1996; 12: 229-33.
24. Nubiola-Calonge P, Badia JM, Gil MJ, Sancho J, Segura M, Sitges-Serra A. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987; ii: 672-73.
25. Khoo D, Riley J, Waxman J. Control of emesis in bowel obstruction in terminally ill patients. Lancet 1992; 339: 375-76.
26. Mangili G, Franchi M, Mariani A et al. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynaecol Oncol 1996; 61: 345-48.
27. Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 1997; 349: 11-14.